Saltar al contenido
Merck

Adverse drug reactions induced by valproic acid.

Clinical biochemistry (2013-06-25)
Radu M Nanau, Manuela G Neuman
RESUMEN

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with valproic acid use, either as monotherapy or polytherapy with other antiepileptic drugs or antipsychotic drugs. This systematic review discusses valproic acid adverse drug reactions, in terms of hepatotoxicity, mitochondrial toxicity, hyperammonemic encephalopathy, hypersensitivity syndrome reactions, neurological toxicity, metabolic and endocrine adverse events, and teratogenicity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

USP
Valproic acid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
2-Propylpentanoic acid
Supelco
Valproic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Valproic acid, European Pharmacopoeia (EP) Reference Standard